Bed Bath & Beyond to report on Wednesday

Bed Bath & Beyond will announce its first-quarter figures for 2014 on Wednesday. The consensus is for earnings per share of $0.94 and revenue of $2.69 billion.

Bed Bath & Beyond store
Source: Bloomberg

2014 has for not been a good year for Bed Bath & Beyond. The stock is trading at 6068 and is down 24% year to date. The results for the third and fourth quarter of 2013 were weak, and both announcements came with lowered guidance for the next quarter.

The particularly bad winter in North America was blamed in both quarters for the poor performance. We have seen some satiability in the shares price in recent weeks, with the stock trading within the 6000c-6200c range.

The wider US housing market and consumer sentiment is picking up, so the shares price could look to pull back lost ground. Since traders’ expectations have been guided lower twice, and now that winter is behind us, I think we could see some bargain hunting if the figures on Wednesday are good. The outlook will be the key factor here, but for now the 6790 region is the short-term target. 

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.

Find articles by analysts